Filtered By:
Vaccination: Influenza Vaccine

This page shows you your search results in order of date. This is page number 17.

Order by Relevance | Date

Total 1458 results found since Jan 2013.

TWiV 947: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses the prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic, severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters, and how successful immunomodulators for treatment of COVID-19 have opened the pathway for comparative trials.
Source: virology blog - October 22, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation influenza Long Covid marburg virus monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern Source Type: blogs

Healthcare Workers and Nonhealthcare Workers Pro-Vaccination Attitude and Its Associated Factors towards COVID-19 Vaccine Globally: A Systematic Review and Meta-Analysis
CONCLUSION: This meta-analysis revealed that the global estimated pooled prevalence of pro-vaccination attitude towards COVID-19 vaccine among both HCWs and non-HCWs was unsatisfactory. Globally, there is a need for a call for action to cease the crisis of this pandemic.PMID:36262688 | PMC:PMC9576430 | DOI:10.1155/2022/2443785
Source: Interdisciplinary Perspectives on Infectious Diseases - October 20, 2022 Category: Infectious Diseases Authors: Addisu Dabi Wake Source Type: research

Impact of COVID-19 Containment Strategies and Meningococcal Conjugate ACWY Vaccination on Meningococcal Carriage in Adolescents
Conclusions: Meningococcal carriage prevalence was not impacted by public health strategies to reduce severe acute respiratory syndrome coronavirus 2 transmission and is unlikely to be the mechanism for lower meningococcal disease incidence. As international travel resumes and influenza recirculates, clinicians must remain vigilant for signs and symptoms of meningococcal disease. Vaccinating people at the highest risk of invasive meningococcal disease remains crucial despite containment strategies.
Source: The Pediatric Infectious Disease Journal - October 19, 2022 Category: Infectious Diseases Tags: Vaccine Reports Source Type: research

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus RSV) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Vaccine in Adults 50 to 75 Years Old
Conditions:   SARS-CoV-2;   Influenza;   RSV Interventions:   Biological: mRNA-1010;   Biological: mRNA-1345;   Biological: mRNA-1273.214;   Biological: mRNA-1045;   Biological: mRNA-1230 Sponsor:   ModernaTX, Inc. Recruiting
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials